Chiu KW, Lin YC, Li WF, Huang KT, Hsu LW, Wang CC*. The Pre-/Post-Transplant Hepatitis C Antibody Associated with the IL-28B RS8099917 TT Genotype and miRNA-122 Expression May Protect Acute Cellular Rejection After LDLT. Curr Issues Mol Biol. 2024 Nov 10;46(11):12772-12783. doi: 10.3390/cimb46110760. (SCI)
Lin SH, Wu KT(co-first), Wang CC, Huang KT, Hsu LW, Eng HL, Chiu KW*. Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury. Antibodies (Basel). 2024 Jan 16;13(1):7. (non-SCI) (ESCI)
Lin SH, Wu KT(co-first), Wang CC, Liu TT, Eng HL, Chiu KW*. Immunohistochemistry Staining-Proven CytomegalovirusColitis in Living Donor Liver Transplantation. Viruses. 2023 Jan; 15(1):115. (SCI)
Lin SH, Wu KT(co-first), Wang CC, Huang KT, Chen KD, Hsu LW, Eng HL, Chiu KW*. Liver Graft MicroRNAs Expression in Different Etiology of Acute Jaundice after Living Donor Liver Transplantation. Biology (Basel). 2022 Aug 17;11(8):1228. (SCI)
Lin SH, Wu KT(co-first), Chiu YC, Wang CC, Chiu KW*. Risk factors for gallbladder polyps observed through second-look abdominal sonography in patients with fatty liver disease. Medicine (Baltimore). 2022 Jul 29;101(30):e29643. (SCI)
Lin SH, Wang CC*, Huang KT, Chen KD, Hsu LW, Eng HL, Chiu KW*. Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D after Living Donor Liver Transplantation. Metabolites. 2022 Apr 25;12(5):388. (SCI)
Lin SH, Lin MT, Wang CC, Chen CL, Hu TH, Chiu KW*. Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure. Transplantation. 2022 Feb 1;106(2):e163-e164. (SCI)
[LETTERS TO THE EDITOR]
Lin SH, Wang CC*, Huang KT, Chen KD, Lin CC, Hsu LW, Chiu KW*. Residual Hepatic HCV-RNA in the Native Liver of Living Donor Liver Transplant Recipients with Chronic Hepatitis C: Mini-Review. J Oncol Res Treat. 2022, V7(4):1000188. (Non-SCI)
Lin SH, Chiu KW*, Wang CC*, Eng HL, Cheng YF, Chen CL. Cell Block Biopsy of Portal Vein Thrombosis for Liver Pre-Transplantation Evaluation. Ann Clin Med Case Rep. 2021; V7(5): 1-4. (Non-SCI)
Wang CC, Huang KT, Chen KD, Hsu LW, Lin CC, Chiu KW*. Hepatic miR-122 expression correlated with IL-28B genetic polymorphisms in hepatocellular carcinoma patients with living donor liver transplantation. ScienceAsia 2021 Oct; 47(5): 578-584. (SCI)
Lin SH, Wu KT, Wang CC*, Huang KT, Chen KD, Lin CC, Hsu LW, Chiu KW*. HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation. J Int Med Res. 2021 Aug;49(8):3000605211034945. (SCI)
Chiu KW*, Lin TL, Yong CC*, Lin CC, Cheng YF, Chen CL. Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report. BMC Gastroenterol. 2019 Feb 28;19(1):37. (SCI)
Chiu KW, Goto S, Nakano T, Hu TH, Chen DW, Huang KT, Hsu LW, Chen CL. Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation. Liver Int. 2018 Dec;38(12):2287-2293. (SCI)
Chiu KW*, Lin TL, Yong CC*, Lin CC, Cheng YF, Chen CL. Complications of percutaneous liver biopsy in living donor liver transplantation: Two case reports. Medicine (Baltimore). 2018 Oct;97(40):e12742. (SCI) [Case Report]
Chiu KW*, Eng HL, Cheng YF, Jawan B, Chen CL. Application of percutaneous liver biopsy on living donor liver transplantation. Int J Clin Exp Med. 2018 Oct;11(10):10372-10379. (SCI)
Chiu KW*, Nakano T, Hu TH, Chen KD, Hsu LW, Eng HL, Cheng YF, Goto S*, Chen CL. Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation. Biomed Res Int. 2018 Mar 19;2018:4508085. (SCI)
Chiu KW*, Nakano T, Chen KD, Hu TH, Lin CC, Hsu LW, Chen CL, Goto S*. Identification of IL-28B genotype modification in hepatocytes after living donor liver transplantation by laser capture microdissection and pyrosequencing analysis. Biomed Res Int. 2018 Mar; 2018:1826140. (SCI)
Chiu KW*, Nakano T, Chen KD, Lin CC, Hu TH, Goto S, Chen CL. Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation. PLoS One. 2016 Jun 8;11(6):e0156846. (SCI)
Chiu KW*, Chiou SS, Lu LS, Wu CK, Eng HL. Molecular Identification of Biliary Isospora Belli: A Case Report. Medicine (Baltimore). 2016 Mar;95(10):e3071. (SCI)
Chiu KW*, Nakano T, Chen KD, Hsu LW, Lai CY, Huang CY, Cheng YF, Goto S, Chen CL. Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation. PLoS One. 2015 May 15;10(5):e0124943. (SCI)
Chiu KW*, Lu LS, Wu TC, Chiou SS. Novel low-cost endoscopic cap for esophageal foreign objects: a case report. Medicine (Baltimore). 2015 May;94(17):e796. (SCI)
Chiu KW*, Lu LS, Chiou SS. High-level disinfection of gastrointestinal endoscope reprocessing. World J Exp Med 2015 February 20; 5(1): 33-39. (non-SCI)
Chiu KW*, Lu LS, Wu CK. High pressure air jet in the endoscopic preparation room: risk of noise exposure on occupational health. Biomed Res Int. 2015;2015:610582. Epub 2015 Feb 1. (SCI)
Chiu KW*, Wu CK, Lu LS, Eng HL, Chiou SS. Diagnostic pitfall of sebaceous gland metaplasia of the esophagus. World J Clin Cases 2014 July 16; 2(7): 311-315. (non-SCI)
Lin MT, Chou YP, Hu TH*, Yu HC, Hsu YC, Tsai MC, Tseng PL, Chang KC, Yen YH, Chiu KW*. Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections. Arch Virol. 2014 Jan;159(1):29-37. (SCI)
Chiu KW, Nakano T, Chen KD, Hsu LW, Lai CY, Chiu HC, Huang CY, Cheng YF, Goto S, Chen CL*. Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in the living donor liver transplantation. World J Hepatol 2013 Nov 27; 5(11): 642-648.
Chiu KW, Nakano T, Chen KD, Hsu LW, Lai CY, Chiu HC, Huang CY, Cheng YF, Goto S, Chen CL*. Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in living donor liver transplantation. World J Hepatol. 2013 November 27; 5(11): 642-648.
Chiu KW* and Chiu SS*. Endoscopic Biopsy as Quality Assurance for Endoscopic Services. Plos one. 2013 Nov 12;8(11): e78557. (SCI)
Chiu KW*, Nakano T, Chen KD, Lai CY, Hsu LW, Chiu HC, Huang CY, Cheng YF, Goto S, Chen CL*. Pyrosequencing to identify homogeneous phenomenon when using recipients/donors with different CYP3A5*3 genotypes in living donor liver transplantation. PLoS One. 2013 Aug 8;8(8):e71314. (SCI)
Chiu KW*, Hu TH, Nakano T, Chen KD, Lai CY, Hsu LW, Tseng HP, Chiu HC, Cheng YF, Goto S, Chen CL. Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients. Transplant Res. 2013 Apr 23;2(1):6.
Lu LS, Hung FC, Chuah SK, Chiu KW*, Hu TH, Cheng YF, Chen CL. Recurrent gastric varices bleeding after living-related liver transplantation successfully eradicated by splenic artery embolization. Hepatogastroenterology. 2012 Jul-Aug;59(117):1586-8. (SCI)
Chiu KW*, Tsai MC, Wu KL, Chiu YC, Lin MT, Hu TH*. Surveillance cultures of samples obtained from biopsy channels and automated endoscope reprocessors after high-level disinfection of gastrointestinal endoscopes. BMC Gastroenterol. 2012 Sep 3;12:120. (SCI)
Lu LS, Wu KL, Chiu YC, Lin MT, Hu TH, Chiu KW*. Swab culture monitoring of automated endoscope reprocessors after high-level disinfection. World J Gastroenterol. 2012 Apr 14;18(14):1660-3. (SCI)
Chiu KW, Nakano T, Tseng HP, Cheng YF, Jawan B, Eng HL, Goto S, Chen CL*. Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation. Hepatogastroenterology. 2012 May;59(115):805-8. (SCI)
Chiu KW, Lu LS, Wu KL, Lin MT, Hu ML, Tai WC, Chiu YC, Chuah SK, Hu TH*. Surveillance culture monitoring of double-balloon enteroscopy reprocessing with high-level disinfection. Eur J Clin Invest. 2012 Apr;42(4):427-31. (SCI)
Chiu KW, Nakano T, Hu TH, Tseng HP, Cheng YF, Jawan B, Eng HL, Goto S, Chen CL*. Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation. Eur J Clin Invest. 2012 Apr;42(4):352-6. (SCI)
Chiu KW, Nakano T, Hu TH, Tseng HP, Cheng YF, Jawan B, Eng HL, Goto S, Chen CL*. Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation. Ann Transplant. 2010 Oct-Dec;15(4):38-43. (SCI)
Chiu KW, Tai WC, Nakano T, Tseng HP, Cheng YF, Jawan B, Goto S, Chen CL*. Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation. Clin Transplant. 2010 Nov-Dec;24(6):830-4. (SCI)
Chiu KW*, Fong TV, Wu KL, Chiu YC, Chou YP, Kuo CM, Chuah SK, Kuo CH, Chiou SS, ChangChien CS. Surveillance culture of endoscope to monitor the quality of high-level disinfection of gastrointestinal reprocessing. Hepatogastroenterology. 2010 May-Jun;57(99-100):531-4. (SCI)
Hu ML, Tai WC, Chuah SK, Chiu YC, Wu KL, Chou YP, Kuo CM, Hu TH, Chiu KW*. Gastric metastasis of hepatocellular carcinoma via a possible existing retrograde hematogenous pathway. J Gastroenterol Hepatol. 2010 Feb;25(2):408-12. (SCI)
Fong TV, Hung FC, Chiu KW*, Chiu YC, Wu KL, Kuo CH, Kuo CM. Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients. Hepatogastroenterology. 2008 May-Jun;55(84):1055-8. (SCI)
